dolasetron and Colonic Inertia

dolasetron has been researched along with Colonic Inertia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wilkes, G1
Aapro, M; Alberto, P; Boyce, M; Busch, B; Kirchner, V; O'Grady, P1

Trials

1 trial(s) available for dolasetron and Colonic Inertia

ArticleYear
Early clinical trial of MDL 73.147 EF: a new 5-HT3-receptors antagonist for the prevention of chemotherapy-induced nausea and vomiting.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:6

    Topics: Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Constipation; Female; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Quinolizines; Serotonin Antagonists; Vomiting

1993

Other Studies

1 other study(ies) available for dolasetron and Colonic Inertia

ArticleYear
Antiemetic agents.
    Oncology (Williston Park, N.Y.), 2007, Volume: 21, Issue:8 Suppl

    Topics: Administration, Oral; Anorexia; Antiemetics; Antineoplastic Agents; Aprepitant; Asthenia; Constipation; Diarrhea; Drug Interactions; Dyspepsia; Fatigue; Fever; Granisetron; Headache; Hiccup; Humans; Indoles; Injections, Intravenous; Isoquinolines; Morpholines; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinolizines; Quinuclidines; Vomiting

2007